I have a friend in the hospital getting surgery. I can't wait to tell him what happened while he was sleeping.
Someone is trying to push it lower at the end of the day. Hope buyers step in. The real trick will be getting the stock over the $5 mark. Milestones like that can be hard to breach. Hopefully tomorrow will be a continuation.
The one thing I didn't hear on the call is a timeline for the first patient to be treated. I think they said mid year but it wan't clear. I am expecting a patient to infuse in July. I hope that is accurate.
With this news ZIOP has finally become a TCR stock to watch. As analyst said if successful this stock will move much higher. I think with the start of a phase 2 in IL-12 combo and the infusion of the first TCR patient this stock should be several dollars higher than the current stock price.
Hopefully we can hit $10 again by the end of the year and maybe much higher.